Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Trial of NRX 194204 in Castration- and Taxane-Resistant Prostate Cancer

This study has been completed.
Information provided by (Responsible Party):
Io Therapeutics Identifier:
First received: November 13, 2011
Last updated: February 23, 2016
Last verified: February 2016
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: December 2015
  Primary Completion Date: December 2015 (Final data collection date for primary outcome measure)